MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval in the US, after getting the go-ahead ...
Just a few months after it was formed by a merger of two psychedelic drug developers, AtaiBeckley has been snapped up by Eli ...
A national newborn screening programme for spinal muscular atrophy (SMA) will be rolled out in England, to give babies the ...
Thousands of people in England and Wales with a type of chronic heart failure (CHF) could soon be eligible for treatment with ...
The European Commission has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, making it the first oral ...
Any uncertainty about whether the second Trump administration would prioritise healthcare fraud enforcement was put to rest ...
Fresh from signing an alliance with Novartis, Chai Discovery has raised $400 million in a third-round financing to support ...
Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of ...
An alarming study has found that people who suffer a serious heart attack are more likely to have micro and nanoplastics ...
New biotech Avere Therapeutics has taken a fast-track to becoming a publicly listed company by merging with NextCure, with a ...
The University of Oxford has launched what it says is the world's first phase I clinical trial of a vaccine specifically ...
A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on its blockbuster immunology drug Enbrel. In a move viewed as a test of states' ability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results